BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $622,000 | -11.6% | 522,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $704,000 | 0.0% | 522,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $704,000 | -15.6% | 522,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $834,000 | -11.7% | 522,000 | -16.1% | 0.00% | -50.0% |
| Q1 2015 | $945,000 | -12.7% | 622,000 | -29.3% | 0.00% | 0.0% |
| Q4 2014 | $1,083,000 | – | 880,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 6,195,000 | $9,377,000 | 2.84% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $10,750,000 | 1.09% |
| Man Investments (CH) AG | 1,100,000 | $1,482,000 | 0.73% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 22,554,000 | $30,444,000 | 0.47% |
| SSI INVESTMENT MANAGEMENT LLC | 3,124,000 | $4,202,000 | 0.45% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 20,000 | $22,373,000 | 0.42% |
| Calamos Advisors LLC | 35,219,000 | $47,628,000 | 0.33% |
| LINDEN ADVISORS LP | 2,500,000 | $3,370,000 | 0.23% |
| Calamos Wealth Management LLC | 513,000 | $694,000 | 0.17% |
| LOOMIS SAYLES & CO L P | 477,810 | $50,323,000 | 0.15% |